Skip to content
A Midwestern Doctor@MidwesternDoc · Oct 28, 2026

At a private JP Morgan conference, Pharma investors were shown a chart projecting America's obesity rate going UP as…

8 tweets1 min read♥ 2Koriginal

Summary

A thread alleges that pharmaceutical companies and investors view GLP-1 drugs like Ozempic as lifetime medications since weight returns when people stop taking them, with evidence including a standing ovation at a JP Morgan conference when presented with data showing obesity rates rising alongside Ozempic prescriptions. The thread claims the industry has aggressively marketed these drugs to children, paid advocacy groups to promote them, and downplayed serious side effects including pancreatitis and eating disorders, while the actual obesity epidemic is driven by subsidized unhealthy foods.

Summarized by ThreadOut AI from the full thread. May miss nuance — read the thread below.

  1. #1

    At a private JP Morgan conference, Pharma investors were shown a chart projecting America's obesity rate going UP as Ozempic prescriptions rose. They didn't gasp. Calley Means told Rogan they gave it a standing ovation. Why? Because the trials show when people stop the drug, the weight comes back, in proportion to how much they lost. That makes it a lifetime drug. Here's how that market was built. 🧵

  2. #2

    MEANS: "the investors clap like seals, standing ovation... because it's a lifetime drug, because it's a crash diet. It's liquid anorexia." And "more than 50% of the people that even have insurance funding for it go off of it within six months."

  3. #3

    I covered that conference. JP Morgan's invite-only healthcare event in January 2023 hyped obesity and Alzheimer's drugs to investors as the next big moneymakers. The keynote speaker was FDA commissioner Robert Califf. After I publicized it, parts of it were deleted, including Califf's keynote listing. Days before he spoke, the FDA had given a controversial Alzheimer's drug a backdoor approval.

  4. #4

    Then came the kids. The FDA approved semaglutide for obese children 12 and up just before the conference. On the conference's first day, the American Academy of Pediatrics published guidelines strongly endorsing GLP-1s for children. And when the kids stopped taking the drug, they began regaining the weight.

  5. #5

    A month of Ozempic costs $1,000 to $1,500, so the industry went after everyone who could get it covered. The manufacturer even paid the NAACP to lobby for the drug, framing any opposition as perpetuating systemic racism. And a coalition it funds is pushing Medicare coverage that could cost $3.1 to $6 billion a year.

  6. #6

    The side effects aren't trivial. In a study of 16 million medical records, versus another weight loss combination, GLP-1 users had 9.09x the risk of pancreatitis, 4.22x bowel obstruction and 3.67x gastroparesis, which is often permanent. Doctors are also noticing an epidemic of Ozempic-facilitated eating disorders. Fen-phen, the last weight-loss craze, was pulled for severe heart and lung damage.

  7. #7

    The drug was never the fix. Here's what's actually driving the obesity epidemic, starting with the subsidized crops and engineered foods on your plate, and how the industry turned it into a lifetime market: midwesterndoctor.com/p/the-great-oz…

  8. #8

    We need real medicine so I've dedicated myself to exposing Pharma corruption and revealing life-changing therapies the medical cartel buried. If you want to support this mission please give me (@MidwesternDoc) a follow and visit me on Substack! midwesterndoctor.com